Wearable Device and Self-Regulation Strategies to Promote Physical Activity Among Children With Cancer: A Pilot Study

May 26, 2025 updated by: Ke Liu

This is a clinical trial that tested whether a 12-week exercise program using smart wristbands and personalized goal-setting could help children with cancer become more active, feel more confident about exercising, and improve their quality of life.

The study included 72 children and teenagers (ages 6-18) receiving cancer treatment at two hospitals in China. They were divided into two groups:

Intervention group (33 children): Used a smart wristband to track daily steps, followed a personalized exercise plan, and received weekly guidance.

Control group (39 children): Continued with usual care (no special exercise program).

The main questions it aims to answer are:

  1. Does the exercise program help children with cancer move more and sit less;
  2. Can it boost their confidence to stay active and improve their physical and emotional well-being?

Study Overview

Detailed Description

What did the study find?

  • Children in the exercise group:

    • Increased active time: They did more moderate-to-vigorous exercise (like brisk walking or playing) by the end of the program.
    • Walked more steps daily: From about 2,200 steps/day at the start to over 6,300 steps/day after 12 weeks.
    • Felt more confident: They believed they could keep exercising even during treatment.
    • Improved well-being: Parents and children reported better physical energy, mood, and social interactions.
  • Comparison with the control group:

    • The exercise group showed much greater improvements than the group without the program.

What does this mean for families? This study suggests that combining wearable devices (like step trackers) with simple goal-setting and family support may help children with cancer stay active during treatment. Staying active could reduce fatigue, improve mood, and support recovery.

What's next? While these results are promising, larger studies are needed to confirm the long-term benefits and safety of such programs.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • GuangZhou, Guangdong, China, 510080
        • Sun Yat-sen University Cancer prevention Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 6 and 18 years old;
  • Children diagnosed with leukemia, lymphoma, or solid tumor confirmed by pathology or bone marrow examination;
  • Obtaining informed consent from the child and their guardian;
  • Approval from the attending physician for participation in physical activity interventions.

Exclusion Criteria:

  • Children diagnosed with mental health disorders;
  • Individuals with severe physical disabilities incompatible with physical activity participation;
  • Cases involving metastasis to bone tissue that would restrict movement.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Smart wristband to track daily steps, followed a personalized exercise plan, and received weekly guidance

Researchers will conduct a comprehensive evaluation for each pediatric patient, including:

  • Disease status and clinical characteristics
  • Patient and family knowledge regarding physical activity (PA)
  • Availability of social support systems

Based on assessment findings, two structured educational sessions (20-30 minutes each) will be delivered, covering:

  • Disease-specific knowledge and PA guidelines
  • Practical strategies for safe exercise (e.g., intensity adjustment, injury prevention)
  • Interactive demonstrations of age-appropriate movement techniques

Patients will co-develop personalized PA plans using the six-step self-regulation framework from the ITHBC (Integrative Theory of Health Behavior Change), including:

  • Short/long-term goal formulation
  • Progress monitoring tools
  • Barrier problem-solving protocols
Patients will perform PA 3-5 times weekly (20-30 minutes/session) aligned with individualized goals, adhering to oncology-specific safety guidelines

Mondays: Curated PA educational content (e.g., home-based exercise videos, fatigue management tips) will be disseminated via the WeChat platform.

Sundays: Scheduled telehealth check-ins with patients and caregivers to:

  • Review PA adherence and experiential feedback
  • Address knowledge gaps through tailored coaching
  • Reinforce behavior change techniques (e.g., self-monitoring logs)
Regular monitoring and evaluation will be conducted to assess PA outcomes: comprehensive evaluations will identify barriers (e.g., treatment-related fatigue) and guide real-time adjustments to the exercise plan based on the patient's physical condition and performance. To enhance adherence, families will collaboratively set alarm reminders for PA sessions, and caregivers will be invited to supervise daily activities.
Placebo Comparator: Control group
Routine health education
Children in the control group received routine health education, which included cancer-related treatment, care, and general health education (e.g., treatment-related, diet, and exercise) without systematic PA health education. Every four weeks, knowledge related to sports activities, the harms of insufficient physical activity, and the benefits of increasing physical activity were pushed through the WeChat platform. During the hospitalization of the child patient, they can voluntarily participate in the activities organized by social workers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
physical activity
Time Frame: From enrollment to the end of treatment at 12 weeks
This study assessed physical activity (PA) patterns in children with cancer using the Children's Leisure Time Activities Study Survey-Chinese version (CLASS-C), a culturally adapted instrument developed by thVigorous PA (e.g., running, basketballe Chinese University of Hong Kong through rigorous forward-backward translation and validation. The CLASS-C captures time spent in specific activities over the past 7 days through 21 items, recording frequency (e.g., days/week) and duration (minutes/session) across three intensity categories:Light PA (e.g., walking, stretching); Moderate PA (e.g., cycling, dancing).
From enrollment to the end of treatment at 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
physical activity self-efficacy
Time Frame: From enrollment to the end of treatment at 12 weeks
Physical activity (PA) self-efficacy in children with cancer was evaluated using the Chinese Short Version of the Physical Activity Self-Efficacy Scale (SPASES-C), a culturally adapted instrument derived from the original 8-item SPASES through rigorous forward-backward translation and psychometric validation. The SPASES-C assesses confidence in overcoming barriers to PA via 7 Likert-type items scored from 1 ("not confident at all") to 4 ("very confident"), yielding a total range of 7-28 points. Higher total scores reflect stronger self-efficacy beliefs (e.g., 7 = minimal confidence, 28 = maximal confidence). Internal consistency (Cronbach's α = 0.87) and construct validity (CFI = 0.93) were established in pediatric populations through prior studies.
From enrollment to the end of treatment at 12 weeks
quality of life of children with cancer
Time Frame: From enrollment to the end of treatment at 12 weeks
This study utilized the Pediatric Quality of Life Inventory™ Generic Core Scales Version 4.0 (PedsQL™ 4.0 Generic Core Scales) to assess the quality of life (QoL) in children diagnosed with cancer. The PedsQL™ 4.0 is a widely validated instrument designed to measure core dimensions of health-related quality of life in pediatric populations aged 2 to 18 years, including physical, emotional, social, and school functioning. Each item is scored on a 5-point Likert scale (0 = never a problem; 4 = almost always a problem), which is then reverse-scored and linearly transformed to a 0-100 scale, where higher scores indicate better quality of life. Thus, the total score as well as subscale scores range from 0 (worst QoL) to 100 (best QoL), with higher values reflecting fewer problems and greater perceived well-being.
From enrollment to the end of treatment at 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2023

Primary Completion (Actual)

July 30, 2024

Study Completion (Actual)

December 25, 2024

Study Registration Dates

First Submitted

May 17, 2025

First Submitted That Met QC Criteria

May 26, 2025

First Posted (Actual)

June 4, 2025

Study Record Updates

Last Update Posted (Actual)

June 4, 2025

Last Update Submitted That Met QC Criteria

May 26, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • L2023SYSU-HL-025
  • 2024-FXY-299-Peds Onc (Other Identifier: Sun Yat-Sen University Cancer Center)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data cannot be shared due to ethical restrictions protecting participant privacy, institutional data governance policies, and the absence of explicit consent for public data sharing in the original study protocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on In-Hospital Program

Subscribe